What is MDLive?
Founded in 2009 and based in Miramar, Florida, MDLive offers comprehensive telehealth solutions, including urgent care, primary care, mental health, and dermatology services accessible via phone or video. The company has consistently sought strategic capital to expand its reach and enhance its service offerings. Its business model focuses on providing convenient and accessible healthcare, a critical need in today's market. The company's history of diverse funding rounds, from private equity to debt financing, indicates a robust strategy for scaling operations and technological development.
How much funding has MDLive raised?
MDLive has raised a total of $271.6M across 5 funding rounds:
Private Equity
$23.6M
Series B
$50M
Private Equity
$50M
Other Financing Round
$123M
Debt
$25M
Private Equity (2014): $23.6M with participation from Heritage Group, Sutter Health, Kayne Anderson Capital Advisors, L.P., and Sentara Healthcare
Series B (2015): $50M, investors not publicly disclosed
Private Equity (2018): $50M supported by Health Velocity Capital
Other Financing Round (2020): $123M featuring Cigna
Debt (2020): $25M, investors not publicly disclosed
Key Investors in MDLive
Cigna
Cigna is a global health company focused on improving health and vitality through innovative solutions. Their involvement suggests a strategic alignment with expanding access to healthcare services.
Heritage Group
Heritage Group is an investment firm that offers a comprehensive suite of services for commercial real estate, with a focus on investment management and property optimization. Their participation may indicate an interest in the operational and infrastructural aspects of healthcare delivery.
Health Velocity Capital
Health Velocity Capital is an investment firm exclusively focused on innovative healthcare software and services businesses, aiming to create a more affordable and sustainable healthcare future.
What's next for MDLive?
The recent major strategic investment signals a new phase of expansion for MDLive, likely focusing on enhancing its technological infrastructure, broadening its service portfolio, and potentially exploring new market segments. The company's ability to attract substantial enterprise-level funding suggests strong investor confidence in its business model and future prospects. Future growth may involve deeper integration with health systems, further development of AI-driven diagnostic tools, and expanding its network of healthcare providers to meet increasing demand for virtual care solutions.
See full MDLive company page
